A Phase II, Open Label Prospective Single Center Drug Study Evaluating the Safety and Efficacy of (+)-Epicatechin in Subjects With Friedreich's Ataxia
Active, no longer recruiting
Phase of Trial: Phase II
Latest Information Update: 02 Nov 2017
At a glance
- Drugs Epicatechin (Primary)
- Indications Friedreich's ataxia
- Focus Therapeutic Use
- 27 Oct 2017 Status changed from recruiting to active, no longer recruiting.
- 26 Sep 2016 Status changed from not yet recruiting to recruiting.
- 09 Feb 2016 New trial record